An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 7063-7070

  Schottelius, Arndt J ^a   Giesen, Claudia ^a   Asadullah, Khusru ^a   Fierro, Iolanda M ^b,d   Colgan, Sean P ^b   Bauman, John ^c   Guilford, William ^c   Perez, Hector D ^c   Parkinson, John F ^c  

^a BAYER PHARMA AG   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAYER AG   (Germany)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI 16 (4 FLUOROPHENOXY)LIPOXIN A4 METHYL ESTER; 15 EPILIPOXIN; ACETYLSALICYLIC ACID; CALCIUM IONOPHORE; CROTON OIL; ILOPROST; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXIN; LIPOXIN A; METHYLPREDNISOLONE ACEPONATE; MEZEREIN; TRIMELLITIC ANHYDRIDE; UNCLASSIFIED DRUG; ZK 158252; CALCIMYCIN; DITERPENE; HYDROXYICOSATETRAENOIC ACID; LEUKOTRIENE B4; NONSTEROID ANTIINFLAMMATORY AGENT; PHTHALIC ANHYDRIDE; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CELL MIGRATION; CONTACT DERMATITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; EDEMA; EPIDERMIS HYPERPLASIA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; ANIMAL; CELL MOTION; CHEMICALLY INDUCED DISORDER; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG ANTAGONISM; GUINEA PIG; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CALCIMYCIN; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; CROTON OIL; DISEASE MODELS, ANIMAL; DITERPENES; FEMALE; GUINEA PIGS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERSENSITIVITY, DELAYED; ILOPROST; INFLAMMATION; LEUKOTRIENE B4; LIPOXINS; MICE; PHTHALIC ANHYDRIDES; SKIN; TERPENES;

EID: 0037114166     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.7063     Document Type: Article

References (43)

1. Serhan, C. N. 1997. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53:107.
2. Fiore, S., and C. N. Serhan. 1990. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med. 172:1451.
3. Chavis, C., I. Vachier, P. Chanez, J. Bousquet, and P. Godard. 1996. 5(S), 15(S)-dihydroxy-eicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J. Exp. Med. 183:1633.
4. Sanak, M., B. D. Levy, C. B. Clish, N. Chiang, K. Gronert, L. Mastalerz, C. N. Serhan, and A. Szczeklik. 2000. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur. Respir. J. 16:44.
5. 4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA. Adv. Exp. Med. Biol. 400B:615.
6. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
7. 4 stable analogs. J. Clin. Invest. 101:819.
8. 4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32:6313.
9. 4 12-hydroxy-dehydrogenase is a multifunctional eicosanoid oxidoreductase. J. Biol. Chem. 275:25372.
10. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34:14609.
11. 4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189:1923.
12. Clish, C. B., J. A. O'Brien, K. Gronert, G. L. Stahl, N. A. Petasis, and C. N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96:8247.
13. 4 block allergen-induced eosinophil trafficking. J. Immunol. 164:2267.
14. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J. Immunol. 164:1029.
15. 4 in human renal mesangial cells. J. Biol. Chem. 275:27566.
16. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:5260.
17. Nicolaou, K. C., J. Y. Rampahl, N. A. Petasis, and C. N. Serhan. 1991. Lipoxins and related eicosanoids: biosynthesis, biological properties, and chemical synthesis. Angew. Chem. 30:1100.
18. 4. J. Biol. Chem. 274:23341.
19. 4 receptor, BLT2. J. Biol. Chem. 276:12454.
20. Ekerdt, R., and B. Müller. 1992. B. Role of prostanoids in the inflammatory reaction and their therapeutic potential in skin. Arch. Dermatol. Res. 284(Suppl. 1):S18.
21. Marks, F., G. Furstenberger, and E. Kownatzki. 1981. Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 41:696.
22. Berg, D. J., M. W. Leach, R. Kuhn, K. Rajewsky, W. Muller, N. J. Davidson, and D. Rennick. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182:99.
23. Mufson, R. A., S. M. Fischer, A. K. Verma, G. L. Gleason, T. J. Slaga, and R. K. Boutwell. 1979. Effects of 12-O-tetradecanoylphorbol-13- acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3′:5′-monophosphate, and induction of mouse skin. Cancer Res. 39:4791.
24. Dearman, R. J., J. A. Mitchell, D. A. Basketter, and I. Kimber. 1992. Differential ability of occupational chemical contact and respiratory allergens to cause immediate and delayed dermal hypersensitivity reactions in mice. Int. Arch. Allergy Immunol. 97:315.
25. Goka, J., and M. J. G. Farthing. 1987. The use of 3,3′,5,5′-tetramethylbenzidine as a peroxidase substrate in microplate enzyme-linked immunosorbent assay. J. Immunoassay 8:29.
26. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
27. Buttgereit, F. 2001. Mechanism of action and effects of glucocorticoids. Z. Rheumatol. 60:117.
28. 4 and regulation of vascular and inflammatory responses. Am. J. Pathol. 158:3.
29. 4 receptor antagonist, SC-41930. Inflammation 14:727.
30. Wilmer, J. L., F. G. Burleson, F. Kayama, J. Kanno, and M. I. Luster. 1994. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J. Invest. Dermatol. 102:915.
31. Haas, J., T. Lipkow, M. Mohamadzadeh, G. Kolde, and J. Knop, 1992. Induction of inflammatory cytokines in murine keratinocytes upon in vivo stimulation with contact sensitizers and tolerizing analogues. Exp. Dermatol. 1:76.
32. 4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced IL-8 release. J. Exp. Med. 187:1285.
33. Krueger, J. G., J. F. Krane, D. M. Carter, and A. B. Gottlieb. 1990. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 94:135S.
34. Gottlieb, S. L., P. Gilleaudeau, R. Johnson, L. Estes, T. G. Woodworth, A. B. Gottlieb, and J. G. Krueger. 1995. Response to psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med. 1:442.
35. Kulke, R., E. Bornscheuer, C. Schluter, J. Bartels, J. Rowert, M. Sticherling, and E. Christophers. 1998. The CXC receptor 2 is overexpressed in psoriatic epidermis. J. Invest. Dermatol. 110:90.
36. Grossman, R. M., J. Krueger, D. Yourish, A. Granelli-Pipemo, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal, and A. B. Gottlieb. 1989. Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86:6367.
37. Zeiss, C. R., J. H. Mitchell, P. F. Van Peenen, J. Harris, and D. Levitz. 1990. A twelve-year clinical and immunologic evaluation of workers involved in the manufacture of trimellitic anhydride (TMA). Allergy Proc. 11:71.
38. Lauerma, A. I., B. Fenn, and H. I. Maibach. 1997. Trimellitic anhydride-sensitive mouse as an animal model for contact urticaria. J. Appl. Toxicol. 17:357.
39. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49:230.
40. Bonnans, C., I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez. 2002. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am. J. Respir. Crit. Care Med. 165:1531.
41. 4. Nat. Med. 8:1018.
42. Oliveira, S. H., C. M. Hogaboam, A. Berlin, and N. W. Lukacs, 2001. SCF-induced airway hyperreactivity is dependent on leukotriene production. Am. J. Physiol. 280:L1242.
43. 4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 51:1178.